BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Investor
TransEnterix Prices Public Offering Of Common Stock 4/15/2014  More...
300,000 Orion Corporation A-Shares Converted Into B-Shares 4/15/2014  More...
Protea Biosciences, Inc. Commences Stock Trading 4/15/2014  More...
Report From Orexo AB (ORXOF)’s Annual General Meeting, 15 April 2014 4/15/2014  More...
CEL-SCI (CVM) Prices $10 Million Public Offering Of Common Stock And Six Month Warrants 4/14/2014  More...
Regado Biosciences, Inc. (RGDO) Announces Pricing Of Public Offering Of Common Stock 4/14/2014  More...
Endo Health Solutions Inc. (ENDP) Announces Extension Of Consent Date And Expiration Date In Exchange Offers And Consent Solicitations For Its 7% Senior Notes Due 2019, 7.00% Senior Notes Due 2020 And 7-1/4% Senior Notes Due 2022 4/14/2014  More...
Decisions Of The Annual General Meeting Of Biohit 4/14/2014  More...
Rich Pharmaceuticals Warns Investors Of Unauthorized Spam Stock Promotion 4/14/2014  More...
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/14/2014  More...
Active Biotech AB (BTPC) - Notice Of Annual General Meeting Of Shareholders 4/14/2014  More...
Synta Pharmaceuticals (SNTA) Enters Into Agreement To Sell $5.0 Million In Common Stock Directly To An Affiliate Of Synta Board Member Bruce Kovner 4/14/2014  More...
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Six Month Warrants 4/14/2014  More...
Report Of Transactions In Zealand Pharma  (ZEAL.CO)’s Shares And Related Securities By Executives And Their Related Parties 4/11/2014  More...
Vitrolife (VITR.ST) Release: Summary Annual Report 2013 In English 4/11/2014  More...
Relypsa, Inc. (RLYP) Announces Pricing Of Public Offering Of Common Stock 4/11/2014  More...
Moberg Pharma AB (Formerly known as Moberg Derma) Annual Report 2013 4/11/2014  More...
Assembly Pharmaceuticals And BioCrossroads Announce Investment To Advance Potentially Curative Therapy For Chronic Hepatitis B Virus 4/11/2014  More...
Hansa Medical's Rights Issue Oversubscribed 4/11/2014  More...
MorphoSys AG: Announcement Of The Convening Of The AGM In Munich/Germany On 23 May 2014 According To Sec. 121 Para. 4a Aktg With The Objective Of Europe-Wide Distribution 4/11/2014  More...
Immunomedics, Inc. (IMMU) To Ring Opening Bell And Host R&D Day At The NASDAQ Stock Market 4/10/2014  More...
Highlights From Innate Pharma (IPH.PA )'s R&D Update Today In New York 4/10/2014  More...
BioPorto Release: Development Of Annual General Meeting 4/10/2014  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Closing Of $10 Million Underwritten Offering 4/10/2014  More...
Constitution Of The Board Of Directors In Genmab A/S (GEN.CO) And Grant Of Warrants To Employees 4/10/2014  More...
Veloxis Pharmaceuticals A/S (VELO)- Passing Of Annual General Meeting 4/10/2014  More...
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/10/2014  More...
Resolutions Of The Ordinary General Meeting Of Shareholders Of Basilea Pharmaceutica (BSLN.SW) 4/10/2014  More...
Resolutions Of The Annual Shareholders' Meeting Of Sartorius AG 4/10/2014  More...
Invitation To The AGM Of NeuroVive Pharmaceutical AB 4/10/2014  More...
NeuroVive Pharmaceutical AB Stock Now Trading In The USA On The OTC Market 4/10/2014  More...
Galapagos NV (GLPG.BR) Raises €2.4 Million Through Warrant Exercises 4/10/2014  More...
Endo Health Solutions Inc. (ENDP) Amends Exchange Offers And Consent Solicitations For Its 7% Senior Notes Due 2019, 7.00% Senior Notes Due 2020 And 7 1/4% Senior Notes Due 2022 4/9/2014  More...
Relypsa, Inc. (RLYP) Announces Proposed Public Offering Of Common Stock 4/9/2014  More...
Pivotal Therapeutics Inc. Grants Incentive Stock Options 4/9/2014  More...
Passing Of Genmab A/S (GEN.CO)’ Annual General Meeting 4/9/2014  More...
Kindred Bio (KIN) Announces Closing Of Initial Public Offering And Exercise Of Over-Allotment Option 4/9/2014  More...
Ipsen (IPN.PA) Eligible For PEA-PME And Included In CAC® PME Index By Euronext 4/9/2014  More...
Northwest Biotherapeutics (NWBO) Again Sets Feuerstein Record Straight; Corrects His False Claims 4/8/2014  More...
Ohr Pharmaceutical (OHRP) Announces $18 Million Registered Direct Offering Of Common Stock 4/8/2014  More...
Notice Of Annual General Meeting In Karo Bio AB 4/8/2014  More...
Argos Therapeutics, Inc. (ARGS) Announces Filing Of Its Annual Report On Form 10-K 4/8/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR) Grants Stock Options Under Inducement Program 4/8/2014  More...
Pacira Pharmaceuticals, Inc. (PCRX) Announces Proposed Public Offering Of Common Stock 4/8/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Closing Of Previously Announced Public Offering 4/8/2014  More...
Medivir AB (MVRBF) Release: Annual Report 2013 4/7/2014  More...
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/7/2014  More...
Annual Report 2013 Active Biotech AB (BTPC) 4/7/2014  More...
ARCA biopharma Files Shelf Registration Statement 4/7/2014  More...
Statement By The Board Of Directors Of Meda AB (MEDA-A.ST) 4/4/2014  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Proposed Public Offering Of Common Stock 4/4/2014  More...
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces $10 Million Underwritten Offering 4/4/2014  More...
Zealand Pharma  (ZEAL.CO) Announces Amendment To Its Articles Of Association Following Warrant Issuance 4/4/2014  More...
Kindred Bio (KIN) Announces Pricing Of Public Offering 4/4/2014  More...
Intercept Pharmaceuticals (ICPT) Announces Pricing Of Public Offering 4/4/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Prices Public Offering Of Common Stock 4/3/2014  More...
BioTie Therapies Corp.: Change In The Number Of Votes 4/3/2014  More...
Resolutions Of The Annual General Meeting Of BioTie Therapies Corp. And Organization Of The Board 4/3/2014  More...
Notice Of Annual General Meeting In Swedish Orphan Biovitrum 4/3/2014  More...
Endocyte, Inc. (ECYT) Closes Public Offering Of Common Stock 4/3/2014  More...
Tauriga Sciences Inc. (TAUG) Updates Its Upcoming Investor Conference And Presentation Schedule Through July 2014 4/3/2014  More...
TapImmune Inc. (TPIV) Is Pleased To Provide An Update On Corporate Events And Milestones For 2014 4/3/2014  More...
Cannabis Therapy Corp. Announces Close Of Restructuring And Confirms Appointment Of Biotech Executive As Director 4/3/2014  More...
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Commencement Of Public Offering Of Common Stock 4/3/2014  More...
Meda AB (MEDA-A.ST)’s Annual Report Is Published 4/2/2014  More...
Zogenix, Inc. (ZGNX) Reports Granting Of Inducement Awards 4/2/2014  More...
Intercept Pharmaceuticals (ICPT) Announces Proposed Public Offering Of Common Stock 4/2/2014  More...
NicOx SA (COX.PA) 2013 Financial Results And Business Update 4/2/2014  More...
BiondVax Pharmaceuticals To Initiate The Process For Trading The Company's Shares In The U.S. Through ADR 4/2/2014  More...
Advaxis, Inc. Announces Closing Of Public Offering Of Common Stock 4/1/2014  More...
Argos Therapeutics, Inc. (ARGS) Added To Russell 2000® And 3000® Indexes 4/1/2014  More...
Status Regarding Novo Nordisk A/S (NVO)'s Holding Of Its Own Shares (31 March 2014) 4/1/2014  More...
Egalet Added To Russell 3000, Russell 2000 And Russell Global Indexes 4/1/2014  More...
Novo Nordisk A/S (NVO) - Share Repurchase Programme 4/1/2014  More...
Celladon Corporation Added To The Russell 2000® And Russell 3000® Indexes 4/1/2014  More...
Zealand Pharma  (ZEAL.CO) Announces The Grant Of Warrants To Its Chief Scientific Officer Under Existing Incentive Scheme 4/1/2014  More...
The Liquid Handling Business Acquisition Escrow Account Funds Returned To Biohit 4/1/2014  More...
ReVance Therapeutics, Inc. (RVNC) Added To Russell 2000® And 3000® Indexes 4/1/2014  More...
Number Of Shares And Votes In Orexo AB (ORXOF) 4/1/2014  More...
Vernalis PLC (VNLPY.PK): Announcement of Results For Year Ended 31 Dec 2013 4/1/2014  More...
Genmab A/S (GEN.CO)’s Total Number Of Voting Rights And Total Share Capital 4/1/2014  More...
Genocea Biosciences Added To Russell 3000® and Russell 2000® Indices 4/1/2014  More...
Eleven Biotherapeutics (EBIO) Added To Russell Indexes On March 31, 2014 4/1/2014  More...
Concert Pharmaceuticals, Inc. (CNCE) Announces Filing Of Its Annual Report On Form 10-K 3/31/2014  More...
INSYS Therapeutics Completes Three-for-Two Stock Split Through Stock Dividend 3/31/2014  More...
Number Of Shares And Votes In Orexo AB (ORXOF) 3/31/2014  More...
Galapagos NV (GLPG.BR) Release: Invitation To The Annual And Extraordinary General Shareholders' Meetings To Be Held On 29 April 2014 3/31/2014  More...
Advaxis, Inc. Announces Full Exercise of Underwriters' Over-Allotment Option 3/31/2014  More...
Number Of Shares And Votes In Orexo AB (ORXOF) 3/31/2014  More...
Royal DSM - Repurchase Of Shares (21 - 27 March 2014) 3/28/2014  More...
IsoRay, Inc. (ISR) Closes $14,675,180 Registered Direct Offering 3/28/2014  More...
Endocyte, Inc. (ECYT) Prices Public Offering Of Common Stock 3/28/2014  More...
TopoTarget A/S Release: Notice To Convene Annual General Meeting 2014 3/28/2014  More...
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/28/2014  More...
Gilead Sciences, Inc. (GILD) Announces Settlement Method For 1.00% Convertible Senior Notes Due 2014 3/28/2014  More...
EXACT Sciences Corporation (EXAS)’ Stock Trading Halted Today; FDA Advisory Committee Meeting To Review Premarket Approval Application 3/27/2014  More...
H. Lundbeck A/S (LUN.CO) Held Its Annual General Meeting On 26 March 2014 At The Company's Registered Office 3/27/2014  More...
New Incentive Plan For Executive Management In H. Lundbeck A/S (LUN.CO) 3/27/2014  More...
Report On Annual General Meeting Held In Neurosearch A/S (NEUR.CO) 3/27/2014  More...
Quintiles, Inc. (Q) Announces Exercise Of The Underwriters' Option To Purchase Additional Secondary Shares 3/27/2014  More...
Generex Biotechnology Corporation (GNBT) Announces $2,075,000 Capital Investment 3/27/2014  More...
Advaxis, Inc. Announces Pricing Of Public Offering Of Common Stock 3/27/2014  More...
Bavarian Nordic (BAVA.CO) - Notice Convening Ordinary General Meeting 3/27/2014  More...
Advaxis, Inc. To Ring The NASDAQ Stock Market Closing Bell 3/26/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) Commences Trading On NYSE MKT Today Under The Symbol ATNM 3/26/2014  More...
Biotage AB (BIOTa.ST) Publishes Its 2013 Annual Report And Corporate Governance Report 3/26/2014  More...
NovaDel Pharma (NVD) Announces Proposed Actions To Complete Liquidation Of Assets And Cash Distribution To Shareholders 3/26/2014  More...
Endocyte, Inc. (ECYT) Announces Proposed Offering Of Common Stock 3/26/2014  More...
Alcobra (ADHD) Announces Shares Uplisted To NASDAQ Global Market 3/26/2014  More...
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/26/2014  More...
Dyax Corp. (DYAX) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/26/2014  More...
Genzyme Corporation (GENZ) Exercises Its Right To Purchase Additional Shares Of Alnylam Pharmaceuticals (ALNY) Common Stock 3/26/2014  More...
TRANSGENE (ENX:TNG) Successfully Completes Rights Issue And Private Placement 3/25/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) To List Common Stock On NYSE MKT 3/25/2014  More...
Orion Corporation: Organising Meeting Of The Board Of Directors 3/25/2014  More...
Trading In Novo Nordisk A/S (NVO) Shares By Board Members, Executives And Associated Persons On 24 March 2014 3/25/2014  More...
Orion Corporation: Decisions By The AGM On 25 March 2014 3/25/2014  More...
Orexo AB (ORXOF)’s Annual Report For 2013 Released 3/25/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - New Articles Of Association 3/25/2014  More...
Resolutions Of The Annual General Meeting Of Oriola-KD Corporation And The Decisions Of The Constitutive Meeting Of The Board Of Directors 3/25/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Commence Trading On NYSE MKT On March 26, 2014 3/25/2014  More...
Antibe Therapeutics Inc. Announces Non-Brokered Private Placement Of $3,000,000 3/24/2014  More...
Publication Of Biohit Oyj Annual Report 2013 3/24/2014  More...
Novo Nordisk A/S - Share Repurchase Programme 3/24/2014  More...
Notice Of Annual General Meeting In BioInvent (BOVNF) 3/24/2014  More...
Tauriga Sciences Inc. (TAUG) Fully Retires The Secured Convertible Promissory Note Held By Typenex Co-Investment, LLC For Original Principal Amount Of $555,000 3/24/2014  More...
Verona Pharma: Results Of Open Offer 3/24/2014  More...
SCYNEXIS, Inc. Announces Launch Of Initial Public Offering Of Common Stock 3/24/2014  More...
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Secondary Offering 3/21/2014  More...
Novo Nordisk A/S (NVO): 2014 Long-Term, Share Based Incentive Programme For Novo Nordisk's Senior Management Board 3/21/2014  More...
BioInvent (BOVNF): Annual Report 2013 3/21/2014  More...
Sangamo BioSciences, Inc. (SGMO) Announces Pricing Of Public Offering Of Common Stock 3/21/2014  More...
Ruthigen Announces Pricing Of Initial Public Offering 3/21/2014  More...
Novo Nordisk A/S (NVO): Resolutions From The Annual General Meeting 3/21/2014  More...
Scilex Pharmaceuticals Announces Completion Of Approximately $5,000,000 Private Placement 3/21/2014  More...
Omeros Corporation (OMER) Closes $40.25 Million Public Offering Of Common Stock 3/20/2014  More...
NovaBay Pharmaceuticals, Inc. (NBY) Announces Pricing Of Public Offering Of Common Stock And Warrants 3/20/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Release: Warrant Programme - Registration Of Capital Increase And New Articles Of Association Following Warrant Exercise 3/20/2014  More...
IntelliPharmaCeutics—Amended Form Of Proxy For Shareholders Meeting To Be Held On March 27, 2014 3/20/2014  More...
TopoTarget A/S Release: Teleconference Regarding Annual Report 2013 3/20/2014  More...
Increased Number Of Biohit Shares Entered Into Trade Register 3/20/2014  More...
Kindred Bio (KIN) Announces Proposed Public Offering 3/19/2014  More...
BIND Therapeutics To Ring The NASDAQ Stock Market Opening Bell On March 26, 2014 3/19/2014  More...
CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy 3/19/2014  More...
Tekmira Pharmaceuticals Corporation Announces Completion Of Underwritten Public Offering Of Common Stock 3/19/2014  More...
Vista Partners Initiates Coverage On Soligenix (SNGX); $5.50 Price Target 3/19/2014  More...
Report On Management’s Transactions With ALK-Abello A/S B-Shares And Associated Securities 3/18/2014  More...
ALK-Abello A/S Release: Grant Of Share Options To Members Of The Board Of Management And Key Employees 3/18/2014  More...
Oxygen Biotherapeutics, Inc. (OXBT) Announces Proposed Public Offering 3/18/2014  More...
Ignyta Announces Underwriters’ Full Exercise Of Option to Purchase Additional Shares in Public Offering of Common Stock 3/18/2014  More...
Genmab A/S (GEN.CO) Summons Annual General Meeting 3/18/2014  More...
Pfizer Inc. (PFE) Launches 2013 Integrated Annual Review 3/18/2014  More...
OvaScience (OVAS) Announces Exercise Of Over-Allotment Option In Public Offering Of Common Stock 3/18/2014  More...
SeeThruEquity Issues Quarterly Update On Boston Therapeutics, Inc. 3/18/2014  More...
Lipocine Inc. (LPCN) To Begin Trading On The NASDAQ Capital Market 3/18/2014  More...
Achaogen (AKAO) Announces Closing Of Initial Public Offering And Exercise Of Underwriters' Over-Allotment Option To Purchase Additional Shares 3/18/2014  More...
Jinchi Biotech Ltd. Intends To List On The National Stock Exchange Of Australia (NSX) And Subsequently In Germany 3/18/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Establishes New Warrant Programme 3/17/2014  More...
Veloxis Pharmaceuticals A/S (VELO) Release: Notice To Convene Annual General Meeting 3/17/2014  More...
Innate Pharma (IPH.PA ): R&D Update On April 10, 2014 In New York 3/17/2014  More...
Novo Nordisk A/S (NVO) - Share Repurchase Programme 3/17/2014  More...
Pivotal Therapeutics Inc. Grants Incentive Stock Options 3/17/2014  More...
Ignyta Announces Pricing Of Public Offering Of Common Stock 3/14/2014  More...
Karo Bio AB Publishes Annual Report 3/14/2014  More...
Royal DSM - Repurchase Of Shares (7 - 13 March 2014) 3/14/2014  More...
Karo Bio AB Publishes Annual Report 3/14/2014  More...
Athersys, Inc. Files Shelf Registration Statement To Replace Prior Shelf 3/14/2014  More...
InterMune, Inc. (ITMN) Announces Pricing Of Public Offering Of 7,500,000 Shares Of Common Stock 3/14/2014  More...
Dyax Corp. (DYAX) Announces Proposed Public Offering of Common Stock 3/14/2014  More...
pSivida Corp (PSDV) Announces $7.0 Million Investment By RA Capital 3/13/2014  More...
Anavex Life Sciences Corp. (AVXL.OB) Announces $10 Million Private Placement Of Convertible Debentures 3/13/2014  More...
Quintiles, Inc. (Q) Announces Pricing Of Secondary Public Offering 3/13/2014  More...
Tekmira Pharmaceuticals Corporation Announces Pricing Of Underwritten Public Offering Of Common Stock 3/13/2014  More...
IntelliCell BioSciences (SVFC) Raises Capital For Strategic Growth 3/13/2014  More...
Capital Increase In Genmab A/S (GEN.CO) As A Result Of Employee Warrant Exercise 3/13/2014  More...
Genmab A/S (GEN.CO) Release: Report Pursuant To Section 28a Of The Danish Securities Trading Act 3/13/2014  More...
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 3/12/2014  More...
Tekmira Pharmaceuticals Corporation Announces Proposed Public Offering Of Common Stock 3/11/2014  More...
Recro Pharma (REPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/11/2014  More...
Cardiome Pharma Corp. (COM.TO) Closes C$30 Million Primary And Secondary Common Share Offering 3/11/2014  More...
Biostar Pharmaceuticals, Inc. (BSPM) Announces Execution Of Agreement For $4.1 Million Registered Direct Offering Of Shares Of Common Stock And Warrants 3/11/2014  More...
CorMedix (CRMD) Announces Close Of Registered Direct Offering 3/11/2014  More...
Quintiles Transnational Corp. Announces Launch Of Secondary Public Offering Of Common Stock 3/10/2014  More...
Novo Nordisk A/S (NVO) - Share Repurchase Programme 3/10/2014  More...
Flamel Technologies (FLML) Announces Pricing Of Public Offering Of American Depositary Shares 3/10/2014  More...
ANI Pharmaceuticals, Inc. Announces Closing Of Public Offering Of Common Stock 3/10/2014  More...
GTx, Inc. (GTXI) Announces Closing Of Private Placement 3/7/2014  More...
Horizon Pharma, Inc. (HZNP) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/7/2014  More...
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces Dividend Record Date To Receive Shares In Its Subsidiary Regen BioPharma 3/7/2014  More...
CytoSorbents, Inc. Announces $10,200,000 Registered Direct Offering 3/7/2014  More...
Columbia Laboratories, Inc. (CBRX) Repurchases 1.4 Million Shares Of Common Stock From Actavis (ACT) 3/7/2014  More...
Biomet Inc. Files For Proposed Initial Public Offering 3/7/2014  More...
Select Medical (SLMC) Announces Proposal To Commence An Offering Of An Additional $110.0 Million Of Its 6.375% Senior Notes Due 2021 3/6/2014  More...
Transgenomic, Inc. (TBIO) Announces $7 Million Convertible Preferred Stock Financing 3/6/2014  More...
Synageva BioPharma (GEVA) Announces Pricing Of Public Offering Of Common Stock 3/6/2014  More...
Pharming Group (PHGUF.PK) Reports On Preliminary Financial Results 2013 3/6/2014  More...
Rockwell Medical (RMTI) To Host Investor Meeting With Nephrology Key Opinion Leader On March 6, 2014 In New York City 3/6/2014  More...
Gentium S.p.A. Announces Decision To Voluntarily Delist American Depositary Shares From The NASDAQ Global Market 3/6/2014  More...
Enzymotec Announces Closing Of Upsized Secondary Public Offering, Including Full Exercise Of The Underwriters' Option To Purchase Additional Shares 3/6/2014  More...
Patheon Inc. (PTI.TO) Shareholders Approve Plan Of Arrangement 3/6/2014  More...





 

//-->